Cantel Medical’s endoscopy sales grew 23.6% in Q2 — 5 insights

Cantel Medical reported its second quarter fiscal year 2018 results.

Advertisement

Here’s what you should know.

1. Cantel Medical had a record quarter. The company grew total sales by 15.3 percent year over year, with 10 percent organic growth.

2. The company’s endoscopy division was the strongest performer, increasing sales by 23.6 percent.

3. Cantel ended the quarter with $40 million in cash and $160 million in gross debt.

4. Cantel’s adjusted EBITDA increased 16.2 percent year over year.

5. Cantel’s U.S.-based business also had a strong quarter with a 7.9 percent increase in 2017 over 2016’s sales.

Cantel’s President and CEO Jørgen B. Hansen said, “We are pleased to report record sales and earnings performance this quarter.”

More articles on gastroenterology:
7 things for ASC leaders to know for Thursday — March 8, 2018
30 statistics on Medicare, Medicaid cases at ASCs
ASC physician workload by region — 21 statistics

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.